Conversion of non-fibrillar β-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation

Biochemical and Biophysical Research Communications

Volumn 361, Issue 4, 2007, Pages 916-921

  Benseny Cases, Núria ^a   Cócera, Mercedes ^a   Cladera, Josep ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Amyloid; Fibril; Fluorescence; Infrared; Oligomer

Indexed keywords

AMYLOID PROTEIN; OLIGOMER; THIOFLAVINE;

ALZHEIMER DISEASE; ARTICLE; BETA SHEET; ELECTRON MICROSCOPY; INFRARED SPECTROSCOPY; KINETICS; PRIORITY JOURNAL; PROTEIN AGGREGATION;

AMYLOID BETA-PROTEIN; FLUORESCENT DYES; KINETICS; MICROSCOPY, ELECTRON, TRANSMISSION; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THIAZOLES;

EID: 34547947641     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.07.082     Document Type: Article

References (21)

1. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron 6 (1991) 487-498
2. Bossy-Wetzel E., Schwarzenbacher R., and Lipton S.A. Molecular pathways to neurodegeneration. Nat. Med. 10 Suppl (2004) S2-S9
3. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 (2001) 741-766
4. Makin O.S., Atkins E., Sikorski P., Johansson J., and Serpell L.C. Molecular basis for amyloid fibril formation and stability. Proc. Natl. Acad. Sci. USA 102 (2005) 315-320
5. Harper J.D., and Lansbury Jr. P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66 (1997) 385-407
6. Caughey B., and Lansbury P.T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26 (2003) 267-298
7. Walsh D.M., Hartley D.M., Kusumoto Y., Fezoui Y., Condron M.M., Lomakin A., Benedek G.B., Selkoe D.J., and Teplow D.B. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274 (1999) 25945-25952
8. Kirkitadze M.D., Condron M.M., and Teplow D.B. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J. Mol. Biol. 312 (2001) 1103-1119
9. Dahlgren K.N., Manelli A.M., Stine Jr. W.B., Baker L.K., Krafft G.A., and LaDu M.J. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 277 (2002) 32046-32053
10. Chromy B.A., Nowak R.J., Lambert M.P., Viola K.L., Chang L., Velasco P.T., Jones B.W., Fernandez S.J., Lacor P.N., Horowitz P., Finch C.E., Krafft G.A., and Klein W.L. Self-assembly of Abeta(1-42) into globular neurotoxins. Biochemistry 42 (2003) 12749-12760
11. Huang T.H., Yang D.S., Plaskos N.P., Go S., Yip C.M., Fraser P.E., and Chakrabartty A. Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide. J. Mol. Biol. 297 (2000) 73-87
12. Wood S.J., Maleeff B., Hart T., and Wetzel R. Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta. J. Mol. Biol. 256 (1996) 870-877
13. Hortschansky P., Schroeckh V., Christopeit T., Zandomeneghi G., and Fandrich M. The aggregation kinetics of Alzheimer's beta-amyloid peptide is controlled by stochastic nucleation. Protein Sci. 14 (2005) 1753-1759
14. Otvos Jr. L., Szendrei G.I., Lee V.M., and Mantsch H.H. Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents. Eur. J. Biochem. 211 (1993) 249-257
15. Fraser P.E., Nguyen J.T., Surewicz W.K., and Kirschner D.A. pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys. J. 60 (1991) 1190-1201
16. Buzon V., Padros E., and Cladera J. Interaction of fusion peptides from HIV gp41 with membranes: a time-resolved membrane binding, lipid mixing, and structural study. Biochemistry 44 (2005) 13354-13364
17. Mastrangelo I.A., Ahmed M., Sato T., Liu W., Wang C., Hough P., and Smith S.O. High-resolution atomic force microscopy of soluble Abeta42 oligomers. J. Mol. Biol. 358 (2006) 106-119
18. Goldsbury C.S., Wirtz S., Muller S.A., Sunderji S., Wicki P., Aebi U., and Frey P. Studies on the in vitro assembly of a beta 1-40: implications for the search for a beta fibril formation inhibitors. J. Struct. Biol. 130 (2000) 217-231
19. Lashuel H.A., Hartley D.M., Petre B.M., Wall J.S., Simon M.N., Walz T., and Lansbury Jr. P.T. Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 in vitro accumulate protofibrils, including amyloid pores. J. Mol. Biol. 332 (2003) 795-808
20. Bitan G., Kirkitadze M.D., Lomakin A., Vollers S.S., Benedek G.B., and Teplow D.B. Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. USA 100 (2003) 330-335
21. Blackley H.K., Sanders G.H., Davies M.C., Roberts C.J., Tendler S.J., and Wilkinson M.J. In-situ atomic force microscopy study of beta-amyloid fibrillization. J. Mol. Biol. 298 (2000) 833-840